SCHEMBL4173238

SCHEMBL4173238

c1cc(N(C2CCCC2)N2CCNCC2)ccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.42
NCF1 P14598 1/20 0.42
PLD1 Q13393 1/20 0.42
ROCK1 Q13464 3/20 0.37
CXCR4 P61073 1/20 0.34
ALDH1A1 P00352 3/20 0.33
CYP3A4 P08684 3/20 0.33
CYP2D6 P10635 3/20 0.33
CYP2C19 P33261 3/20 0.33
TSHR P16473 2/20 0.33
ROCK2 O75116 2/20 0.33
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C9 P11712 1/20 0.33
SLC6A4 P31645 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNA4 P43681 1/20 0.32
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
HTR2B P41595 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4177502 0.75 PLD1 (0.43) PLD1ALDH1A1
SCHEMBL10378160 0.74 SIGMAR1 (0.48) SLC6A4HTR2AHTR2CHTR2B
SCHEMBL3714823 0.71 PLD1 (0.48) ADRB2NCF1PLD1ROCK1ALDH1A1
SCHEMBL6240273 0.69 ADRB2 (0.33) ADRB2NCF1PLD1
SCHEMBL24327381 0.68 AOC3 (0.46) ALDH1A1CYP3A4CYP2D6CYP2C19TSHR
SCHEMBL9166944 0.66 AOC3 (0.45) ALDH1A1CYP3A4CYP2D6CYP2C19TSHR
SCHEMBL5349895 0.65 CHRM5 (0.43) ADRB2NCF1PLD1SLC6A4HTR2C
SCHEMBL6240015 0.64 KIT (0.31)
SCHEMBL3949161 0.62 OPRM1 (0.49) ADRB2NCF1PLD1ROCK1CYP2D6
Dalfampridine SCHEMBL28141942 0.62 ADRB2 (0.46) ADRB2NCF1PLD1ROCK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612076-B2 Piperazinyl-pyridine derivatives HOFFMAN-LA ROCHE INC. (US) 2009-11-03 US disclosed
US-20090042903-A1 PIPERAZINYL-PYRIDINE DERIVATIVES NETTEKOVEN MATTHIAS HEINRICH 2009-02-12 US disclosed
US-7456175-B2 Piperazinyl-pyridine derivatives HOFFMAN-LA ROCHE INC. (US) 2008-11-25 US disclosed
US-20060135528-A1 Piperazinyl-pyridine derivatives HOFFMANN-LA ROCHE INC. 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135528-A1 Piperazinyl-pyridine derivatives HRH4, HRH3, H1-3 ADRB2 52/4885NCF1 2799/4885PLD1 3147/4885
US-20090042903-A1 PIPERAZINYL-PYRIDINE DERIVATIVES HRH4, HRH3, H1-3 ADRB2 52/4885NCF1 2799/4885PLD1 3147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.